Results 181 to 190 of about 545,238 (360)

Unraveling the Role of the Microbiota in Cancer Immunotherapy: A New Frontier. [PDF]

Research (Wash D C)
Wang S, Li S, Zhang M, Liu R, Ye X, Mao S, Yu J, Xie X, Tan W.   +8 more
europepmc   +1 more source

TRYPTIG DIGESTION OF AN ANTITUMOR PROTEIN : NEOGARZINOSTATIN

, 1968
SACHIKO KITAME, Hiroshi Maeda, Katsuo Kumagai, Nakao Ishida   +3 more
openalex   +2 more sources

Metal Nanoclusters for Cancer Imaging and Treatment

Advanced Functional Materials, EarlyView.
This review aims to provide a comprehensive summary and discussion of the core–shell design capabilities of metal nanoclusters (NCs) at the atomic level for cancer imaging and treatment. It offers essential insights into the design principles of metal NCs while also encouraging the exploration of other nanomaterials and their potential theranostic ...
Haiguang Zhu, Ziping Wang, Qiaofeng Yao, Ping Zhang, Jianping Xie, Xun Yuan   +5 more
wiley   +1 more source

Recent Advances in the Use of <i>Ganoderma lucidum</i> and <i>Coriolus versicolor</i> Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung Cancer. [PDF]

Pharmaceutics
Zhang H, Wang L, Chan YW, Cho WC, Zuo Z, To KKW.   +5 more
europepmc   +1 more source

Polysaccharides in Lichens and Fungi. III. Further Investigation on the Structures and the Antitumor Activity of the Polysaccharides from Gyrophora esculenta MIYOSHI and Lasallia papulosa LLANO

, 1969
Yoshihiro Nishikawa, Tadahiro Takeda, Shoji Shibata, Fumiko Fukuoka   +3 more
openalex   +2 more sources

Antibody‐Programmable Bimetallic Nanozymes for Transcriptional Blockade Therapy in HER2/ER‐Positive Breast Cancer

Advanced Functional Materials, EarlyView.
Zr‐Fe MOF@Ribociclib@Herceptin (ZFRH) efficiently targets/kills Human Epidermal Growth Factor Receptor 2/Estrogen Receptor‐positive (HER2/ER+) breast cancer cells. It combats tumors by: 1) Elevating ROS, altering redox balance; 2) Inhibiting transcription; 3) Inducing pyroptosis.
Hongkun Miao, Tong Ye, Mingjiang Liu, Jingchao Gao, Lian Tan, Qian Dong, Qingbo Lv, Qianqian Ye, Yu Wang   +8 more
wiley   +1 more source

From pathogen to cure: exploring the antitumor potential of Toxoplasma gondii. [PDF]

Infect Agent Cancer
Alipanahi P, Khosrojerdi A, Pagheh AS, Hatam-Nahavandi K, Ahmadpour E.   +4 more
europepmc   +1 more source

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

Science Translational Medicine, 2018
Y. Lan, Dong Zhang, Chunxiao Xu, K. Hance, Bo Marelli, Jin Qi, Huakui Yu, G. Qin, Aroop Sircar, Vivian M. Hernández, Molly H. Jenkins, Rachel E. Fontana, Amit M. Deshpande, George Locke, H. Sabzevari, L. Radvanyi, K. Lo   +16 more
semanticscholar   +1 more source

Aptamer Functionalized Hydrogel Dressings for Post‐Surgery Tumor Recurrence Inhibition and Tissue Reconstruction

Advanced Functional Materials, EarlyView.
Post‐surgical tumor therapy struggles with recurrence and inefficient healing. Anti‐tumor DNA aptamer functionalized gelatin hydrogels, Apt‐GelMA, simultaneously address both issues by suppressing tumor regrowth via targeted tumor cell inhibition and enhancing wound healing through improved cell adhesion and migration. Their biocompatibility, stability,
Tianyue Li, Xin‐Yi Qian, Zi‐Yuan Li, Hao‐Wen Li, Poh‐Ching Tan, Chenghuizi Hu, Jiajun Jin, Shuang‐Bai Zhou, Qing‐Feng Li, He Tian, Junji Zhang, Itamar Willner   +11 more
wiley   +1 more source

Basic rules to respond to PD-1 blockade cancer immunotherapy. [PDF]

J Immunother Cancer
Ribas A.
europepmc   +1 more source